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In Brief
Monteiro-Sepulveda et al. conduct a
comprehensive obesity-related study of
the absorptive upper intestine. They find
that, relative to lean individuals, obese
subjects have increased jejunal mucosal
surface and an increase in both local
innate and adaptive immune cells.
Increased jejunal T cells, especially at the
epithelial mucosa surface, correlate with
decreased enterocyte insulin signaling.
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In obesity, insulin resistance is linked to inflammation
in several tissues. Although the gut is a very large
lymphoid tissue, inflammation in the absorptive small
intestine, the jejunum, where insulin regulates lipid
and sugar absorption is unknown. We analyzed jeju-
nal samples of 185 obese subjects stratified in three
metabolic groups: without comorbidity, suffering
from obesity-related comorbidity, and diabetic, ver-
sus 33 lean controls. Obesity increased both mucosa
surface due to lower cell apoptosis and innate and
adaptive immune cell populations. The preferential
CD8ab T cell location in epithelium over lamina pro-
pria appears a hallmark of obesity. Cytokine secre-
tion by T cells from obese, but not lean, subjects
blunted insulin signaling in enterocytes relevant to
apical GLUT2 mislocation. Statistical links between
T cell densities and BMI, NAFLD, or lipid metabolism
suggest tissue crosstalk. Obesity triggers T-cell-
mediated inflammation and enterocyte insulin resis-
tance in the jejunum with potential broader systemic
implications.
INTRODUCTION
In obesity, systemic and tissue low-grade inflammation
contribute to metabolic disorders leading to type 2 diabetes
and non-alcoholic fatty liver disease (NAFLD) (Ganeshan and
Chawla, 2014; Johnson and Olefsky, 2013; Vajro et al., 2013).
In humans, the current concepts suggest that the visceral adi-
pose tissue is a major source of inflammation from the accumu-
lation of inflammatory macrophages, NK cells, andmast cells, as
well as T cells (Cancello et al., 2006; Dalmas et al., 2014; Divoux
et al., 2012; Duffaut et al., 2009; O’Rourke et al., 2009; Weisberget al., 2003; Zeyda et al., 2007). In mouse adipose tissue, the
accumulation of CD4+ and CD8+ T cells contribute to macro-
phage recruitment and activation (Nishimura et al., 2009). In
addition, in human and mouse, regulatory T cells are diminished
in obesity thereby lowering anti-inflammatory and insulin-sensi-
tizing effects (Deiuliis et al., 2011; Eller et al., 2011; Feuerer et al.,
2009). In liver, the pro-inflammatory cytokine tonus and insulin
resistance associate with NAFLD (Tran andGual, 2013).Many in-
flammatory mediators have been studied, and TNF-a was the
first cytokine identified that alter insulin sensitivity of tissues, at
least in rodents (Gregor and Hotamisligil, 2011; Hotamisligil
et al., 1993). In human obesity, the contribution of the intestinal
immunity has yet received little attention, despite the large size
of the gut as a lymphoid tissue (Brandtzaeg et al., 1989). This
is particularly intriguing in the jejunum, which is an intestinal
segment where insulin is a regulator of lipid and sugar absorption
(Ait-Omar et al., 2011; Haidari et al., 2002; Tobin et al., 2008).
Therefore, jejunal function is a potential target for local inflamma-
tion and insulin resistance in enterocytes.
The challenging function of the immune system of the gut is to
maintain tolerance to luminal antigens from food and commensal
microbeswhilemaintaining efficient immunity against pathogens
(reviewed in Cheroutre et al., 2011). This relies on a precise orga-
nization of immune cells in the different layers of the intestinal
mucosa. Immune cells colonize the lamina propria and epithe-
lium as well as gut-associated lymphoid structures like Peyer’s
patches, isolated lymphoid follicles (ILFs), and draining mesen-
teric lymph nodes to constitute the intestinal immune barrier.
Whereas T cells reside throughout the mucosa, innate immune
cells and B cells are mainly located in the lamina propria and
lymphoid structures (reviewed in Izcue et al., 2009; Schulz and
Pabst, 2013). Epithelial T cells, mainly CD8+ T cells, are more
abundant in the small than in the large intestine, which is prob-
ably related to the different antigen challenge they face from
food antigens in the small intestine to microbial antigens in the
lower gut (Melgar et al., 2002).
Indeed, gut inflammation and loss of tolerance may lead to se-
vere bowel inflammation or cancer (Izcue et al., 2009; Wang andCell Metabolism 22, 113–124, July 7, 2015 ª2015 Elsevier Inc. 113
Figure 1. Increased Mucosa Size Is Related
to Decreased Apoptosis in Obesity
Lean subjects ([L], n = 22–28, open circle) were
compared to metabolically healthy obese ([MHO],
n = 15–17, open square), obese with at least a
comorbidity ([Ob], n = 26–55, black circle), and
obese diabetic subjects ([ObD], n = 21–50, black
diamond), including the untreated ([ObD-ut], n =
10, open diamond).
(A) Morphology parameters were measured in je-
junal sections (5 mm thick, 10–200 mm2) of the
crypt-villus axis: villus heights (mm, left), crypt
depths (mm, middle), and number of villi per mm
mucosa length taken at stromal tissue junction
(right, 6–12 aligned villi, 2–4 histology images).
Figure S1 shows enterocyte and goblet cell
densities (n/mm2), villus widths, villus/crypt length
ratios, and villi surfaces. Results are given as
scatter plot with bar at geometric mean.
(B) Representative images of proliferating Ki-67+
cells and quantification (mean ± SEM) obtained
in L (n = 12), Ob (n = 15), and ObD (n = 17)
groups.
(C) Representative images of TUNEL assay in
crypt-villus axis (right) with magnification (left)
and quantification (mean ± SEM) of apoptotic
nuclei (n/mm2 mucosa, 12–16 images) performed
in the lamina propria (LP) and the epithelium (EPI)
of subjects displaying short (L, n = 5) and long (Ob,
n = 5) villi. Scale bar 100 mm.
(D) qRT-PCR of Bax and Bcl2 apoptosis markers
of L (n = 7) and Ob (n = 20) expressed as Bax/Bcl2
ratio. Results are expressed as mean ± SEM.
Statistical significance of Mann-Whitney test: *p <
0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.Karin, 2013) with major tissue damage and weight loss. Classical
cytotoxic CD8+ T cells expressing cytokines and cytolytic per-
forin/GzmB are rare in the healthy gut (Melgar et al., 2002) but
are increased in inflammatory bowel diseases (IBDs) and colitis
(Izcue et al., 2009). Interestingly, the prevalence of IBD and can-
cer, including colorectal cancer, is increased in obesity (Calle
and Kaaks, 2004; Versini et al., 2014), suggesting a pro-inflam-
matory microenvironment of gut mucosa in metabolic disease.
In obesity, the inflammatory state of the gut is known essentially
from contrasting measures of nitric acid and calprotectin, two
fecal markers of intestinal inflammation in colon mucosa (Ding
and Lund, 2011) and from reduced microbial gene richness (Co-
tillard et al., 2013).
Here we provide, in Human, a comprehensive picture of
obesity-related alterations of immunity in the jejunum of lean
and obese subjects, distinguishing metabolically healthy
(MHO) subjects from subjects with at least one comorbidity
(Ob) or diabetes (ObD). Immunohistology and flow cytometry
analysis were performed to measure potential alterations of jeju-
nal morphology, immune cell location, density, and phenotype in
the lamina propria and epithelial compartments. We showed that114 Cell Metabolism 22, 113–124, July 7, 2015 ª2015 Elsevier Inc.obesity triggers jejunal inflammation and
a marked attraction of T cells into the
epithelium. T cells impacted the insulin
response of enterocyte, consistent with
an altered location of the GLUT2 sugartransporter. At a broader level, statistical links were established
between jejunal T cell densities and metabolic phenotypes of
obese subjects.
RESULTS
Intestinal Mucosa Hyperplasia Is Related to Decreased
Apoptosis in Obesity
The villus heights and related epithelial surfaceare key factors that
determine the exchanges of the intestinal mucosa with luminal
contents and consequently the size of the immune compartment.
Morphological features were measured in 28 lean and 122 obese
subjects stratified by metabolic status (Figure 1A). Jejunal villus
heights (583 ± 12 mm versus 395 ± 14, p < 0.0001) and crypts
depths (134 ± 3 mm versus 109 ± 5, p < 0.0001) increased in all
obese versus lean groups. The villus widths (117 ± 2 mm) and
number of villi per mucosa length (7 ± 0.1 villi/mm, Figure S1A
and 1A) were unchanged. Accordingly, villi surface (cylinder-like)
calculated from villi heights and widths was 1.5-fold larger (p <
0.0001) inobesegroups than in leangroups, independentofmeta-
bolic status (Figure S1A). The villus to crypt length ratios (index of
Figure 2. Increased Innate Cell Densities
and Maturation of Antigen Presenting Cells
in Obesity
(A) Representative immunohistology images of
macrophages (CD68), mature dendritic (DC-
LAMP), natural killer (NKp46), and mast (tryptase+
and chymase+ in Figure S2A) cells taken in jejunal
sections of L (n = 21–23, open circle), MHO (n = 14–
16, open square), Ob (n = 18–20, black square),
ObD (n = 29–33, black diamond), and ObD-ut (n =
10–12, open diamond) groups. Scale bar 100 mm.
Dot plots of densities (n/mm2, four images) with
bars at geometric mean are shown.
(B) Flow cytometry analysis of percent LinHLA-
DR+ cells in total lamina propria cells ignoring
CD3+, CD56+, CD14+, and CD20+ cells and
percent mDC1+ cells among total cells and CD86+
cells among mDC1+ cells was performed in L (n =
3) and Ob (n = 12) groups. Relative fluorescence
intensity (RFI) is the ratio of mean fluorescence
intensity (MFI) of anti-CD86 antibodies to isotype
controls. Figure S2 shows gating strategy for DC
subset analysis (Figure S2B), the quantification of
rare CD68+DC-Lamp+ cells (Figure S2C), and a
heatmap of correlations between innate cell den-
sities and villus size (Figures S2D and S5). Statis-
tical significance of Mann-Whitney test: *p < 0.05,
**p < 0.01, ***p < 0.001, and ****p < 0.0001.proliferation) increased in obese (4.4 ± 0.1 p = 0.0036) versus lean
(3.8 ± 0.2) groups (Figure S1A). Goblet cell (319± 8 cells/mm2) and
enterocyte (5109 ± 168 cells/mm2) densities were unchanged in
obesity (Figure S1B). Taken together, these results indicate villus
hyperplasia increasing the surface of exchange with luminal
contents.
Hyperplasia is supported by proliferation or longer lifespan of
cells. The Ki-67 proliferation marker was restricted to epithelial
cells in crypts (Figure 1B), and the densities of Ki-67+ cells
were lower (34 ± 4; p = 0.0232) in obese versus lean (54 ± 5)
groups. Therefore, proliferation could not explain taller villi. To
test reduced cell death, a TUNEL assay of apoptotic nuclei
was done in subjects with shortest (L, n = 5) and longest
(Ob, n = 5) villi. In Ob, apoptosis was reduced by 80% in lamina
propria and 60% in epithelium, in both crypt and villus cells.
Accordingly, the Bax/Bcl2 expression ratio was decreased (Fig-
ure 1C), indicating an anti-apoptotic mechanism triggering jeju-
nal mucosa hyperplasia.
Increase Jejunal Innate Cell Densities Depends on
Metabolic Status of Obese Subjects
Activation of the innate immune system is relevant to liver,
pancreas, and adipose tissue inflammation in obesity (Lumeng,
2013). In the jejunum, innate cell populations were evaluated in
24 lean and 90 obese subjects. The location of innate immuneCell Metabolism 22, 113cells in the lamina propria was unchanged
in obesity (Figure 2A). Mast cell densities
were similar in lean and obese groups
(Figures 2A and S2A). Macrophage den-
sity (CD68) increased 1.6-fold in all obese
(156 ± 4 cells/mm2, p < 0.0001) versus
lean (96 ± 7) groups. In lean subjects,mature DC (DC-Lamp) were nearly absent from the lamina prop-
ria, but densities increased 6-fold in Ob (4 ± 1, p < 0.0001) and
11-fold in ObD (8 ± 2, p < 0.0001) groups, including some rare
double positive CD68+DC-Lamp+ cells (Figure S2C). In flow
cytometry analysis, the frequency of LinHLA-DR+ cells and
mDC1 (LinHLA-DR+CD11c+CD1c+) increased, consistent with
elevated mature DC (Figures 2B and S2B). However, the expres-
sion of CD86 costimulatory molecule among mDC1 cells sug-
gested a similar activation in lean and obese subjects. The
mDC2 (LinHLA-DR+CD141+) and pDC (LinHLA-DR+CD303+)
subsets were undetectable (Figure S2B). Similarly, NKp46+ cell
density (14 ± 2) was increased 7.3-fold (p < 0.0001) in Ob and
ObD versus L (2.2 ± 0.5) groups. Interestingly, innate cell den-
sities appear to correlate with mucosa size (Figure S2D). More-
over, mature DC and NK cell densities were similar in MHO
and L groups contrasting with their large increase in metaboli-
cally altered Ob and ObD group. Thus, jejunal innate immunity
is enhanced in obesity with local and metabolic impact.
Obesity Increases the Density of Jejunal T Cells in
Epithelium
Since innate cells are increased in the jejunalmucosa, a concom-
itant change of adaptive immunity can be anticipated. B cell den-
sities (CD20; 16 ± 1 cell/mm2) sitting in lamina propria around
proliferating crypts were unaltered in obesity (Figure S3A). In–124, July 7, 2015 ª2015 Elsevier Inc. 115
Figure 3. Obesity Increases the Density of Jejunal T Cells in Epithelium
(A) Representative immunohistology of CD3+ T cells in lean and obese subjects (left images) and magnifications at mid-villus (right images) showing their
distribution between epithelium (EPI) and lamina propria (LP). Scale bar, 50 mm. T cells densities (cell/mm2) in total mucosa and EPI/LP ratios were calculated for
L (n = 24, open circle), MHO (n = 17, open square), Ob (n = 52, black square), ObD (n = 49, black diamond), andObD-ut (n = 12, open diamond) groups. Results are
given as dot plots with bar at geometric mean. Figures S3A, S3B, S3C, and S5 show B cell densities (CD20), CD3+ T cell densities in EPI or LP and correlations
between T cell and innate cell densities.
(B–D) Flow cytometry analysis of CD4+ and CD8+ T cells in LP and EPI.
(B) The % of CD4+, CD8+, double positive (DP) and double negative (DN) T cells were analyzed among T cells of L (n = 18, open bar) and Ob (n = 27, black bar)
groups. Results in Ob andObDgroupswere statistically similar andmerged. Figures S3D andS3F show a representative gating strategy of T cell phenotyping and
percentage of gd T cells.
(C) Memory status of T cells of L (n = 4 LP & n = 9 EPI) and Ob (n = 13 LP & n = 22 EPI) subjects—i.e., naive (CD45RA+CCR7+), CM (CD45RACCR7+), EM
(CD45RACCR7), and EMRA (CD45RA+CCR7) profiles.
(D) Percentage CD69+ and CD103+ among T cells of L (n = 12, open bar) and Ob (n = 20, black bar) groups. Figure S3E shows percentage of CD62L+, CD27+,
CD28+, and CD25+ cells. Results are expressed as mean ± SEM. Statistical significance of Mann-Whitney test: *p < 0.05, **p < 0.01, ***p < 0.001, and
****p < 0.0001.contrast, total T cell density (CD3/mm2) inObandObD (Figure3A)
increased 1.3-fold (1,840 ± 70, p = 0.0004) as compared to L
(1,370 ± 70) groups. Most striking was the increase of intra-
epithelial T cell densities in obesity increasing by 1.4-fold in116 Cell Metabolism 22, 113–124, July 7, 2015 ª2015 Elsevier Inc.MHO (1,580 ± 140, p = 0.0196) and 1.6-fold in Ob (1,830 ± 70,
p < 0.0001) versus lean (1,120 ± 90) groups (Figure S3B). In the
lamina propria, T cell density was similar in lean (L) (1,960 ± 80)
and Ob+ObD (1,760 ± 100) groups but was lower in MHO
(Figure S3B). Accordingly, the epithelial to lamina propria (EPI/
LP) density ratios increased by 2.0-fold (p < 0.0001) in obesity.
However, diabetes per se did not alter further T cell densities
than in the non-diabetic obese group. These observations reveal
a preferential location of T cells in the epithelium, a hallmark of
obesity in the jejunum. Correlation analysis between innate and
adaptive cells further highlighted the interaction of mature DC
in lamina propria with T cells in epithelium (Figures S3C and S5).
Characterization of the differentiation, homing, and activation
of T cells was performed by flow cytometry, comparing T cell
phenotypes in lamina propria and epithelium of 23 obese and
17 lean subjects. CD4 and CD8 T cell proportions were similar
in Ob and ObD groups, indicating no marked impact of diabetes
per se on T cell phenotype (pooled data; Figure 3B). CD8
proportions among T cells increased, indicating that they
contribute to a global increase of T cells in obesity (Figure 3B).
In contrast, CD4+CD8+ cells (DP) and CD4+ T cell proportions
decreased (Figures 3B and S3D). The gd T cells were a small
and unaltered T cell population in the jejunal mucosa of obese
subjects (Figure S3F). In humans, expression of CD45RA is a
marker of naive versus memory CD4+ and CD8+ T cell. Addi-
tional functional subsets of CD45RA+ or CD45RA T cells are
defined by lymph node homing receptors CCR7 and CD62L.
Naive T cells are CD45RA+CCR7+. Terminally differentiated
effector T cells (TEMRA cells) are CD45RA+CCR7 T cells.
CD45RA memory T cells are subdivided CCR7+ central mem-
ory (CM) cells, able to migrate to lymphoid tissue, as opposed to
CCR7 effector memory (EM) cells in tissues. In the jejunum of
lean and obese groups, T cells were predominantly CD45RA
memory T cells (Figure 3C). In addition, over 70% CD8 T were
CCR7CD62LCD69+CD103+, consistent with non-lymphoid
organ cell homing (Figures 3D and S3E) and effector resident
memory T cell phenotype. Memory phenotypes were similar in
lean and obese groups, suggesting that the trafficking and hom-
ing of T cells toward secondary lymphoid tissue are unaltered. In
addition, obesity did not change the expression of CD27 and
CD28 co-stimulatory molecules (Figure S3E). T cells did not ex-
press CD25 (Figure S3E) relevant to an absence of proliferation
in the lamina propria (Ki-67, Figure 1). Thus, the differentiation
and activation profiles of T cells appear similar in lean and
obese groups, but the proportion of CD8 T cells is increased
in obesity. In addition, CD8 T cells displayed better equipment
for intestinal attraction and homing.
In Obesity, Intra-Epithelial T Cell Enrichment Is by
CD8ab Cells
As CD8ab T cell coreceptor denotes increased T cell sensitivity
to antigen as opposed to CD8aa corepressor effect (Cheroutre
et al., 2011), a first evaluation of T cell activation was performed
by immunofluorescence analysis of ab and aaCD8 co-receptors
in T cells in the lamina propria and epithelium of 13 lean and 108
obese subjects (Figure 4A). In the lamina propria, CD8ab T cell
densities were higher in Ob (384 ± 41 n/mm2, p = 0.0176) and
ObD (360 ± 47, p = 0.0472) groups than in L (216 ± 61). Epithelial
CD8ab T cell densities increased by 2.5- and 2.0-fold, respec-
tively, in Ob (1,530 ± 129, p < 0.0001) and ObD (1,219 ± 109,
p = 0.0002) groups but were similar in MHO (949 ± 225) and
L (622 ± 225) groups, indicating that CD8ab T cells are main con-
tributors to the increase of epithelial CD8 T cells. Concomitantly,CD8aa T cell densities decreased both in the epithelium (L 801 ±
113 n/mm2; MHO 308 ± 68; Ob 352 ± 31; ObD 416 ± 60) and
lamina propria (L 477 ± 84; MHO 221 ± 54; Ob 195 ± 25; ObD
237 ± 36). Accordingly, the 4-fold (p < 0.0001) increase of
CD8ab/CD8aa density ratio in obesity, including in MHO sub-
jects, suggested that the favored epithelial CD8ab T cell location
is independent of the metabolic status of obese subjects.
To further evaluate the potential cytotoxicity of CD8ab T cells,
we performed an immunofluorescence analysis of Granzyme B
(GzmB) expression in jejunal cells (Figure 4B). The low number
of GzmB+ cells was consistent with epithelial integrity. However,
most GzmB+ cells were located in CD8-negative cells of the lam-
ina propria and were increased 2.0- and 2.5-fold in Ob and ObD
subjects, respectively. Mast and NKp46+ cells were the major
contributors to GzmB+ cells (Figures S4A and S4B).
Obesity Enhances Jejunal Inflammation
The functional relevance of increased immune cell densities was
analyzed by qRT-PCR of mRNA expressions of cytokines, che-
mokines, and costimulation factors in lamina propria and epithe-
lial cell fractions containing immune and non-immune cells
(Figure 5A). Cytokines and chemokines (i.e IL-6, IL-17, IL-22,
and CCL2 in lamina propria only and IL-23, TNF-a, TGF-b, and
IFN-g in lamina propria and epithelium) increased in obesity. An-
tigen-presenting (HLA-DR) and costimulation factors (CTLA4
and CD80) were significantly increased only in LP, whereas
CD28, ICOS increased in both LP and EPI fractions. CD3ε
mRNA increased consistent with higher CD3 T cell density.
These profiles revealed enhanced mucosal inflammation and
antigen presentation in the jejunum of obese subjects.
Surprisingly in obesity, reninmRNA increased70-fold in epithe-
lial cells and angiotensin receptor 2 (AGTR2) tended to increase
(Figure 5B). Accordingly, COX2 and IL-17, two downstream tar-
gets of the renin angiotensin system (RAS), were increased.
Considering that IL-23 is a regulator of Th17 expansion, we
explored jejunal T cell cytokine signature by intracellular staining
of Th1 (IFN-g) and Th17 (IL-17, IL-22) (Figure 5C). IL-17 and IL-22
were increased in CD4+ T cells of lamina propria. IFN-g produc-
tion was also increased in obesity due to epithelial CD8 T cells.
These results revealed that jejunal immunity is oriented toward
proinflammatory responses in obesity.
Activated Intestinal T Cells Reduce Enterocyte Insulin
Sensitivity in Obesity
Tissue inflammation inhibits cell responses to insulin (Johnson
and Olefsky, 2013). To evaluate the functional impact of T cells
in the jejunum, we performed an insulin sensitivity assay ex vivo
on mucosa explants and in vitro on human Caco-2/TC7 entero-
cytes in coculture with immuno-selected T cells of obese and
lean subjects. TheSer473Akt phosphorylation in response to insu-
lin was impaired in jejunal explants of obese but not lean subjects
(Figure 6A). Accordingly, soluble factors secreted by activated
T cells of obese subjects strongly decreased PSer473-Akt in
Caco-2/TC7, indicating that they trigger a loss of enterocyte insu-
lin sensitivity (Figure 6B). We observed no counter-insulin effect
with non-activated T cells. Thus, intestinal T cells may contribute
to impaired epithelial insulin sensitivity in obesity.
Cytokines and insulin share some steps in their signaling path-
ways, which may interfere with Akt phosphorylation (Samuel andCell Metabolism 22, 113–124, July 7, 2015 ª2015 Elsevier Inc. 117
Figure 4. Epithelial CD8ab T Cells Are Enriched in Obese Jejunum
(A) Confocal images in representative samples showing the distribution of CD8aa (red) versus CD8ab (yellow) T cells in the mucosa of MHO (left) and obese Ob
(right) subjects. Magnification of boxed epithelial zone (right) with split images of CD8a and CD8b (Scale bar 10 mm). Nuclei are labeled with DAPI (blue).
Quantification of CD8aa and CD8ab T cell densities (cells/mm2) in L (n = 13, open circle), MHO (n = 12, open square), Ob (n = 52, black square), ObD (n = 44, black
diamond), and ObD-ut (n = 10, white diamond) groups are given as dot plots with bar at geometric mean. Histograms (right) show CD8ab/CD8aa T cell density
ratios in LP and EPI according to metabolic status.
(B) Representative confocal image of GzmB expression (green) in CD8+ (red) cells in an obese subject. Scale bar 100 mm and 10 mm. Histograms show the
quantification of LP and EPI GzmB+ CD8 T cells (black bar) and total GzmB+ (open bar) cells in L (n = 11), Ob (n = 14) and ObD (n = 7) subjects. Figure S4
shows GzmB expression in mast and NKp46 cells. Results are expressed as mean ± SEM. Statistical significance of Mann-Whitney test: *p < 0.05, **p < 0.01,
***p < 0.001, and ****p < 0.0001.Shulman, 2012). When cocultured with Caco-2/TC7, lamina
propria T cells of obese subjects secreted more IL-10, IL-9,
IFN-g, TNF-a, GM-CSF, IL-21, IL-17, and IL-22 than T cells of
lean subjects. By comparison, epithelial T cells of obese subjects
only stimulated IFN-g, TNF-a, and GM-CSF secretions (Fig-
ure 6C). Added as recombinant molecules in the basolateral cul-
ture medium, all upregulated cytokines except IL-10 decreased
PSer473-Akt with different potency, confirming their effectiveness
in modulating Caco2/TC7 enterocyte insulin sensitivity (Fig-
ure 6D). These ex vivo experiments revealed that T-cell-derived
proinflammatory cytokines have potential to directly impair in-
testinal insulin response.118 Cell Metabolism 22, 113–124, July 7, 2015 ª2015 Elsevier Inc.T Cell Densities Correlate with Comorbidities in Obesity
To gather information on possible influence of jejunal immunity
on metabolism in obesity, we examined statistical links between
immune cell densities and a series of clinical parameters (Figures
7 and S6). None of the innate or adaptive cell densities were
correlated with subject age (Figure S6; Table S1). We found
some associations between innate immune cells and metabolic
and inflammatory variables (Figure S6).
Depending on T cell location in the intestinal mucosa, we
found several associations between T cells densities and clinical
phenotypes related to systemic inflammation (CRP and leuco-
cytes), body weight (BMI, Leptin), lipid variables (Cholesterol,
Figure 5. Obesity Enhances Inflammatory Responses in Jejunum
(A and B) Gene expression in immune and non-immune cells isolated from lamina propria (LP) and epithelium (EPI) were analyzed by qRT-PCR in L (n = 13) andOb
(n = 24) subjects. RNA levels are normalized to 18S (arbitrary units, AU). Results are given as fold expression in obese over lean (mean ± SEM) in LP (gray bars) and
EPI (hatched bars). Non-detected RNA levels are marked ND.
(A) Genes relevant to mucosal immunity.
(B) Genes relevant to the RAS.
(C) Flow cytometry analysis of intracellular labeling of IL-17A, IL-22, and IFN-g cytokines of CD4+ and CD8+ T cells from LP and EPI, after PMA and ionomycin
stimulation (Lean, n = 8, open bar; n = 20, Ob&ObD, black bar). Results are expressed as mean ± SEM. Statistical significance of Mann-Whitney test: *p < 0.05,
**p < 0.01, and ***p < 0.001.TG, HDL, and Apo B), and markers of liver alterations (ASAT,
ALAT, GGT, and NAS score evaluated by liver histology)
(Figure 7A)—all features frequently associated with severe
obesity. Importantly, T cell accumulation in the epithelium
increased together (positive correlation) with markers of sys-
temic inflammation, corpulence, and liver parameters. Dyslipi-
demia (reduced HDL cholesterol) was associated to higher
epithelial T cell density. The epithelial T cell densities were not
correlated to total calorie intake but were correlated to the con-
sumption of an unbalanced diet with reduced percentage CHO
in lipid-rich diet (Table S1; Figure S6). This suggests that T cell
attraction into the jejunal epithelium is related to an unbalance
diet (i.e., lipid versus CHO).
We previously showed that a pathological accumulation of
GLUT2 in the apical membrane of enterocytes is a hallmark
of insulin resistance. Epithelial CD8 T cell density was
increased in subjects displaying pathological apical GLUT2
location, whereas lean and obese subjects with low CD8
T cell densities displayed a similar absence of apical GLUT2
(Figure 7B).
Altogether, the results indicate that T cell attraction in jejunal
epithelium correlates with local and systemic comorbidities in
obesity.DISCUSSION
In the small intestine of morbidly obese humans, the most salient
changes were mucosal hyperplasia, increased inflammation,
and related impairment of local insulin sensitivity. Yet, jejunal im-
munity is already altered in subjects without apparent metabolic
impairment other than excess weight (MHO). However, type 2
diabetes, regardless antidiabetic treatments, did not further in-
crease jejunal immune cell densities. Although preserving
macroscopic mucosa structure, obesity favors proinflammatory
T cells attraction in the epithelium. T cells isolated fromobese but
not lean subjects reduce enterocyte insulin response via proin-
flammatory cytokines. Local T cell inflammation increases
together with obesity comorbidities.
A prominent feature of obesity in the small intestine is the
asymmetrical distribution of T cells in favor of an epithelial loca-
tion independently of metabolic status. Attraction of T cells in
epithelium is through CCL5 chemokine and CD103 integrin,
increasing epithelial anchoring via E-cadherin (Gebhardt and
Mackay, 2012). This is consistent with increased resident
T cells driving epithelial inflammation in obesity. In the jejunum
of obese subjects, CD8 T cells infiltration can reach up to
50% of epithelial cells through higher CD8ab+ over CD8aa+Cell Metabolism 22, 113–124, July 7, 2015 ª2015 Elsevier Inc. 119
Figure 6. Soluble Factors Secreted by
T Cells of Obese Subjects Impair Insulin
Response of Enterocytes
(A) Representative western blots of PSer473-Akt and
total Akt in jejunal mucosa explants after insulin
stimulation and quantification in L (n = 3, open bar)
and Ob (n = 6, black bar) groups.
(B) Immuno-selected CD3+ cells (33 106 cells/well)
from lamina propria (LP) and epithelium (EPI),
activated or not by anti-CD3 and anti-CD28, were
placed at the basolateral side of Caco-2/TC7 cells
for 48 hr. Left: representative western blots of
PSer473-Akt and total Akt in Caco-2/TC7 cell ly-
sates. Right: Quantification of insulin response of
Caco-2/TC7 cells alone (gray bar) and in coculture
with T cells of L (n = 8) and Ob (n = 8) groups.
(C) Multiplex analyses of cytokine production (GM-
CSF, IFN-g, IL-10, IL-13, IL-17A, IL-22, IL-9, IL-2, IL-
21, IL-4, IL-5, IL-31, and TNF-a) by Caco2/TC7-CD3
Tcell coculture.When statistically different, cytokine
secretions are given as fold increase of cytokine
secretion inObnormalized to L value (dotted line) for
LP (gray bars) and EPI (hatched bars) T cells.
(D) Insulin stimulation of PSer473-Akt in Caco-2/TC7
cells alone (gray bar) and exposed to recombinant
cytokines (black bars; 10 ng/ml IL-10, IL-9, L-21,
IL-17A, and IL-22; 50 ng/ml IFN-g, TNF-a, and
GM-CSF; and 5 ng/ml cytokine mix). Results are
expressed as fold increase of PSer473-Akt/ Total
Akt in response to insulin. Mann-Whitney test
compared Caco-2/TC7 cells in the presence of
recombinant cytokines with unstimulated controls.
Results are expressed as mean ± SEM. Statistical
significance of Mann-Whitney test: *p < 0.05, **p <
0.01, ***p < 0.001, and ****p < 0.0001.T cell infiltration, meaning oriented immune responses in obesity.
In lean conditions, high CD8aa+ T cells in epithelium and lamina
propria denote a lower capacity to secrete proinflammatory
cytokines than CD8ab+ T cells (Cheroutre et al., 2011). Thus,
increased CD8ab+ and lower CD8aa+ T cells in obesity support
local secretion of proinflammatory cytokines.
Increased CD8+ T cell population is a feature of tissue inflam-
mation in obesity. T cell abundance in adipose tissue is corre-
lated with BMI (Duffaut et al., 2009; Kintscher et al., 2008). Our
work shows that the small intestine is also a site of immune
remodeling in human obesity, although phenotypic differences
concerning cell cytotoxicity appear when compared to other
tissues and diseases. GzmB+ CD8 T cells increase in the
epididymal fat of diet-induced obese mice (Yang et al., 2010).
High CD8+ T cell infiltration is found in acute inflammation in
IBD, which is a condition of major deregulation of intestinal
immune responses. Increased GzmB+ CD8 T-cell-mediated
cytotoxicity in active IBD contributes to decrease intestinal bar-
rier integrity and inflammatory tonus (reviewed in Geremia
et al., 2013). Here, the integrity of the jejunal mucosa is pre-
served despite high epithelial CD8 T cell infiltration, consistent
with low and unaltered GzmB expression as reported in healthy
subjects (Melgar et al., 2002). Therefore, obesity promotes the
infiltration of CD8+ T cells without GzmB cytotoxicity in the je-
junal epithelium.
In obesity, inflammation contributes to insulin resistance in
adipose tissue, liver, muscle, pancreas, and brain. Obesity in-120 Cell Metabolism 22, 113–124, July 7, 2015 ª2015 Elsevier Inc.creases CD4+ and CD8+ T cell proinflammatory cytokine secre-
tion in adipose tissue and activation of downstream signaling
pathways that trigger insulin resistance as shown in rodents
(Duffaut et al., 2009; Gregor and Hotamisligil, 2011; Kintscher
et al., 2008; Samuel and Shulman, 2012; Yang et al., 2010).
The jejunal epithelium (Ait-Omar et al., 2011; Haidari et al.,
2002; Tobin et al., 2008) and the duodenum (Veilleux et al.,
2014) are sites of insulin action. Here, soluble factors secreted
by activated T cells isolated from obese but not lean subjects
have the potency in vitro to decrease insulin response in enter-
ocytes. The high density of T cells probably reinforces this phe-
nomenon in obesity. In addition to the known effect of TNF-a
on insulin signaling, we show a reduction of enterocyte insulin
response by GM-CSF; IFN-g; IL-9; IL-21; and, most potently,
by IL-17 and IL-22. The increase of Th17/Th22 T cells in
jejunum is consistent with previous observations in peripheral
blood and adipose tissue in obesity (Dalmas et al., 2014;
Zhao et al., 2014). In the intestine, IL-17 and IL-22 appear
essential to maintain mucosal barrier function. Patients with co-
litis show Th17/Th22 cell depletion in the mucosa in link with
local perturbation of tissue-biopsied microbiota (Leung et al.,
2014). On the other hand, the invalidation of IL-22 receptor in
mouse colon has deleterious effect on weight gain and blood
glucose deregulation (Wang et al., 2014). One might thus spec-
ulate that some cytokines such as IL-22 have a ‘‘yin yang
regulatory effect’’ in the intestine; a local rise could trigger the
protection of mucosa function in human obesity while in the
Figure 7. Epithelial T Cell Densities Correlate with Subject Comor-
bidities and Pathological Location of GLUT2 in Obesity
(A) Heatmap of correlations between T cell densities and clinical variables. For
quantitative variables, Pearson or Spearman correlations were used de-
pending on the fulfillment of hypotheses required for parametric tests. Each
colored square denotes a correlation at the intersection of columns and lines.
Color intensity (color key) indicates the correlation coefficient magnitude using
the red color for positive correlation (parameters increase together) and blue
for negative correlation (one parameter increases when the other decreases).
Significant correlations are identified by stars *p < 0.05 and **p < 0.01. Full
correlation of innate and adaptive cell densities with clinical parameters,
including sample sizes, correlation coefficients for each intersection, and
p values, are given in Figure S6.
(B) Obese ([Ob], n = 32) and lean ([L], n = 13) subjects were sorted according to
the location of GLUT2 in the apical membrane of enterocytes (Apical GLUT2).
The epithelial to lamina propria (EPI/LP) density ratios of CD3CD8 T cells were
calculated according to the presence (yes) or absence (no) of apical GLUT2 in
L (no, n = 13/13) and Ob subjects (yes, n = 23; no, n = 9). Results are expressed
as mean ± SEM. Statistical significance of Mann-Whitney test of means
between lean and obese: ***p < 0.001.meantime it could contribute to local metabolic response
impairment. Furthermore, we observed higher IL-10 secretion
in jejunal lamina propria T cells in obesity, presumably adding
to an already complex intestinal homeostasis (Shouval et al.,
2014).
Local inflammation may contribute to jejunal insulin resis-
tance and alter intestinal functions. Here, densities of immune
cells increase together with corpulence, leptin, dyslipidemia,
and liver dysfunction, suggesting organ crosstalk. Indeed,
severe intestinal inflammation in Crohn’s disease is associated
with intestinal (mesenteric) fat hypertrophy (Peyrin-Biroulet
et al., 2007). In rodents, the migration and proliferation of
T cells in the intestine promote local inflammation in response
to a high-fat diet (Veldhoen and Brucklacher-Waldert, 2012).
In humans, lipid-rich diets are often characterized by low car-
bohydrate content. We show that epithelial T cell accumulation
increases in obese subjects consuming a high-fat/low-carbohy-
drate diet, which display pathological apical GLUT2 in accor-
dance with local insulin resistance from cytokine actions. This
is congruent with the correlation between systemic insulin
resistance (HOMA-IR) and mucosal T cell infiltration in non-dia-
betic obese subjects.
We also found a large increase of renin and proinflammatory
Cox2 gene expressions in the jejunal epithelium in accordance
with enhanced RAS in obesity. RAS activation results in proin-
flammatory and fibrotic actions in the adipose tissue as well as
trophic effects via an unbalanced cell apoptosis/proliferation
(Fa¨ndriks, 2010). Here, obesity-related RAS activation may
have trophic effect on human small intestine via villi hyperplasia
and decreased apoptosis.
Whereas observational by nature, this is a human compre-
hensive study underscoring the part played by the upper
intestine in obesity-related inflammation. The innate and
adaptive immune responses of the absorptive intestine may
be an efficient protective mechanism against luminal chal-
lenges. The specific increase of Th17/Th22 T cells raises new
hypothesis for targeted therapy. Modulating intestinal inflam-
mation in relation to nutrient and jejunal microbiota might
be a future goal to gain control on whole-body metabolic
deterioration.Cell Metabolism 22, 113–124, July 7, 2015 ª2015 Elsevier Inc. 121
EXPERIMENTAL PROCEDURES
Human Subjects and Jejunal Tissue Sampling
Obese subjects (218 jejunal samples from 185 obese and 33 lean) were strat-
ified according to their metabolic status based on the IDF Consensus
Worldwide Definition of the Metabolic Syndrome (http://www.idf.org/
metabolic-syndrome) adding insulinemia (<20 mU/l) to take insulin sensitivity
into account. Three groups were constituted (i) metabolically healthy obese
subjects ([MHO], n = 19) exempt from cardio metabolic risk displaying a
HOMA-IR < 3, (ii) non-diabetic obese subjects with at least one comorbidity
(Ob, n = 97), and (iii) type 2 diabetic obese subjects (ObD; n = 69) either
receiving antidiabetic treatment or untreated (ObD-ut, n = 16/69).
A lean group ([L]; n = 33; BMI = 22 kg/m2 [range 19–25]) was constituted with
either jejunal biopsy donors (n = 5) (double balloon endoscopy; normal histo-
pathology; absence of anti-inflammatory treatment) or jejunal samples taken
at distance of pancreatic or gastric tumor during duodenal resection in
absence of chemotherapy or apparent metabolic consequence (n = 28). Avail-
able clinical descriptions are in Table S1. Since morphology and immune cell
densities in lean subjects were similar whatever the origin of samples, it sug-
gested a low level of confounding inflammation, and data were pooled.
Obese subjects,mainly females, were prospectively recruited between 2006
and 2013while attending the Nutrition Department at Pitie´-Salpeˆtrie`re Hospital
in the Institute of Cardiometabolism and Nutrition (ICAN). Patients met the
following criteria for obesity surgery: BMIR 40 kg/m2 orR 35 kg/m2 with at
least one comorbidity (hypertension, type 2 diabetes, dyslipidemia, or obstruc-
tive sleep-apnea syndrome) in agreement with international and national
guidelines. Preoperative evaluation of subjects included detailed, long-term
medical history of obesity and dietary evaluation of calorie and macronutrient
intake by a registered dietician. Liver biopsies and staging of liver alterations
were performed as in Bedossa et al. (2012). Informed written consent was
obtained from all subjects, following French legislation regarding Ethics and
Human Research (Huriet-Serusclat). The Comite´ Consultatif de Protection
des Personnes dans la Recherche Biome´dicale Ile de France 1 approved the
study, which was conducted in accordance with the Helsinki Declaration
and registered in a public trials registry (ID Number: CT 0476658; https://
clinicaltrials.gov/ct2/show/NCT00476658?term=poitou&rank=1).
Proximal jejunal samples (60–70 cm distal to the ligament of Treitz) were
collected from surgical waste (4 cm). Tissue was rapidly opened, washed in
DMEM (1 g Glucose Glutamax + pyruvate + 10% SVF + 1% PS) and kept at
4C before cell isolation, fixation and paraffin imbedding, or freezing at80C.
Immunohistology
Immunohistology of jejunum (5 mm paraffin-embedded tissue sections) was
performed in 28 lean (BMI: 19–25 kg/m2) and 122 obese (BMI: 35–68 kg/m2)
patients, including 18 MHO, 55 Ob, 37 ObD, and 12 ObD-ut subjects. Primary
antibodies were tryptase (AA1), CD68 (KP1), DC-LAMP (1010E1.01), CD20
(L26), Ki-67 (MIB-1), and CD3 rabbit polyclonal (A0452) (DAKO); chymase
(422818) and NKp46 (MAB1850) (R&D Systems); CD8a (SP16) (Spring biosci-
ences); CD4 (Ab8 clone 4B12) (Thermo Scientific); and CD8b (SC25277)
(Santa-Cruz). Primary antibodies or corresponding isotype were incubated
for 1 hr at RT and revealed with a streptavidin biotin peroxidase kit (BioSpa
GMR4-61), DAB staining (DAKO), and nuclei hematoxylin counterstaining
(Vector). Images were obtained by conventional microscopy or whole slide
imaging for rare events (Nanozoomer, Hamamatsu). For immunofluorescence
analysis, primary antibodies were revealed with secondary antibodies coupled
to fluorophores (SouthernBiotec) and images acquired by confocal micro-
scopy (LSM710 Zeiss) (Ait-Omar et al., 2011). Number of villi per mmmucosa,
villus width, crypt to tip height, crypt depth (mm), lamina propria, and epithelial
immune cell densities (cell/mm2), excluding lymphoid structures, were
analyzed in longitudinal sections ofmucosa in two to four fields (ImageJ 1.46c).
Cell Isolation
The jejunal mucosa was dissected and minced prior incubation in chelating
buffer (5 mM EDTA, 2 mM DDT, PBS; 20 min; 37C). Released epithelial cells
were filtered through 70 mmmesh cell strainers, centrifuged (6003 g at 4C for
5min), and recovered in complete DMEM (10%FCS, 1%PS). Sucrase activity,
used as a witness of enterocyte contamination of lamina propria by epithelial
cells, was below 2% of total mucosa activity. Epithelial immune cells were en-122 Cell Metabolism 22, 113–124, July 7, 2015 ª2015 Elsevier Inc.riched at the interface of a 40%/70% Percoll gradient (GE Healthcare Life Sci-
ences). Cells of the lamina propria, including lymphoid tissue, were isolated
from fibrous matter by collagenase D digestion (1 mg/ml, Roche; 2 hr, 37C).
Red blood cells were removed in lysis buffer (154 mM NH4Cl, 10 mM
KHCO3, and 0.1mMEDTA). Freshly isolated cells were used for flow cytometry
analysis of immune subsets.
Cell Surface Markers and Intracellular Cytokine Staining
To characterize lamina propria and epithelial cells, freshly isolated cells were
retrieved in FACS buffer (PBS, 2% FCS, 2 mM EDTA) and stained (30 min,
4C, dark) with the following antibodies: FITC-anti-CD8 (SK1; BioLegend),
APC-AlexaFluor750-anti-CD27 (CLB-27/1; Invitrogen), EDC-anti-CD45RA
(2H4LDH11LDB9; Beckman Coulter), AlexaFluor700-anti-CD3 (UCHT1),
BV421-anti-CD4 (RPA-T4), PE-anti-CD25 (M-A251), PE-anti-CD28 (CD28.2),
PE-anti-CD56 (B159), APC-anti-CD62L (DREG-56), APC-H7-anti-CD69
(FN50), PE-anti-CD103 (Ber-ACT8), PE-Cy7-anti-CCR7 (3D12), and APC-
anti-gdTCR (B1) (BD Biosciences). DC populations were identified using
a lineage (Lin) mixture of VioGreen-conjugated mAb against CD56 (HCD56 ;
BioLegend), CD20 (LT20), CD3 (BW264/56), and CD14 (TU¨K4) with CD45-
APC-Vio770 (5B1), HLA-DR-PerCP (AC122), CD11c-APC (MJ4-27G12),
CD1c-PE (AD5-8E7), CD303-FITC (AC144), CD141-VioBlue (AD5-14H12),
and CD86-PE-Vio770 (FM95) (Miltenyi Biotec) plus a dead cell viability marker
(eBioscience). For intracellular cytokine analysis, cells were stimulated with
phorbol-12-myristate-13-acetate and ionomycin in the presence of GolgiStop
(Dalmas et al., 2014). Cells were stained (30 min, 4C, dark) with anti CD45,
CD3, CD4, and CD8 surface markers plus a fixable viability marker; fixed;
and made permeable with Foxp3 fixation/permeabilization kit (eBioscience)
prior incubation with PE-anti-IL-17A (eBio64CAP14), PE-Cy7-anti-IL-22
(22URTI) (eBioscience), and FITC-anti-IFN-g (4S.B3, BD Biosciences) or iso-
type-control mAbs. Cells were analyzed on a LSRII flow cytometer (BD Biosci-
ences) using FACS Diva software (BD Biosciences). Data were analyzed with
FlowJo 10.0.6 (Tree Star).
Coculture of Caco-2/TC7 Enterocytes with Jejunal T Cells and
Cytokine Assay
Lamina propria and epithelial T cells were immuno-selected from jejunal cell
suspensions by CD3 positive selection (Miltenyi Biotec). Human Caco-2/TC7
enterocytes were grown on Transwell filters (Costar, Corning) (Tobin et al.,
2008) until differentiationandplaced for 48hr on topCD3+Tcells inwells coated
with anti-CD3 (2.5 mg/ml; UCHT1, eBioscience) containing 15 mM glucose
complete DMEM and anti-CD28 (1 mg/ml; 37407; R&D Systems). After the
48 hr, cytokines were analyzed in basolateral supernatant by a 13 MILLIPLEX
Human Th17 Panel (X-MAP technology, Millipore) (i.e., GM-CSF, IFN-g, IL-2,
IL-4, IL-5, IL-9, IL-10, IL-13, IL-17A, IL-21, IL-22, IL-31, and TNF-a).
Insulin Sensitivity Assay
Fresh jejunal mucosae from lean and obese subjects were pre-incubated in
serum-free DMEM for 30 min prior insulin stimulation (15 mU/ml DMEM,
10 min, 37C). Sample homogenization (Fast Prep MP24) was performed in
ice-cold lysis buffer (Millipore) containing an anti-phosphatase and anti-prote-
ase inhibitor cocktail (Complete Mini Protease Inhibitor Cocktail (Roche diag-
nostics) (Ait-Omar et al., 2011). The insulin stimulation of Caco-2/TC7 cells was
performed at the end of 48 hr coculture with isolated T cells or after a 24 hr
challenge with recombinant cytokines keeping in proportions found in cocul-
ture cytokine secretion assays or with amix of 5 ng/ml cytokine to evaluate ad-
ditive effects. Insulin action was assayed in half of filters, and the other half was
kept as a control. Cell lysis in ice-cold buffer (1% Triton X-100, 0.5% deoxy-
cholic acid, 150mMNaCl, 5mMEDTA, 20mMTris [pH 7.4], anti-phosphatase,
and anti-protease inhibitors). Protein (50 mg, BCA, Uptima) homogenates were
denatured in 0.125 M Tris-HCl (pH 6.8), 20% glycerol, 4% SDS, and 10%
b-mercaptoethanol and were analyzed by western blot for P-ser473Akt and
total Akt (Cell Signaling) using ECL (Pierce ECL2 Substrate). Quantification
of immuno reactive bands was by a LAS 4000 (GE Healthcare Bio-Sciences
AB) imaging densitometer and Multigauge software (Fujifilm corporation).
RNA Analysis
Total RNA of lamina propria and epithelial fractions were extracted with the
RNeasy Mini kit (QIAGEN). RNA concentration and quality were assessed
(2100 Bioanalyzer, Agilent Technologies) before reverse transcription of 1 mg
total RNA (Applied Biosystems) and qPCR. RNA quality, quantity, and RT effi-
ciency were normalized to ribosomal 18S RNA.
Statistical Analyses
Results are presented as mean ± SEM or scatter plots with bar at geometric
mean, and means were compared by a Mann-Whitney test (Graphpad Prism,
GraphpadSoftware). Correlations analyses were done using the R statistical
software and the graphical gplots package. Data were transformed using
the Boxcox algorithm when response variable transformation was improving
the model linearity based on the log likelihood criterion. Correlations were
performed with the Pearson parametrical test when the required hypotheses
of normality (either Shapiro-Wilk or Kolmogorov-Smirnov test, depending on
the sample size), linearity (95% CI on the Boxcox lambda parameter), and ho-
moscedasticity (Breusch-Pagan test) were fulfilled. The Spearman’s rho statis-
tic was calculated otherwise. Heatmaps were produced from the correlation
coefficients using ‘‘heatmap.2’’ in the gplots package. A p value less than
0.05 was considered statistically significant and coded as *p < 0.05, ** p <
0.01, *** p < 0.001, and **** p < 0.0001.
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